Found: 6
Select item for more details and to access through your institution.
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 3, p. 141, doi. 10.1007/s40801-019-00161-y
- By:
- Publication type:
- Article
Post-authorisation Safety Study of Pioglitazone Use and Safety Endpoints of Interest in Denmark After Direct Healthcare Professional Communication.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 3, p. 133, doi. 10.1007/s40801-019-0160-6
- By:
- Publication type:
- Article
From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not Work.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 3, p. 125, doi. 10.1007/s40801-019-0159-z
- By:
- Publication type:
- Article
PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 3, p. 115, doi. 10.1007/s40801-019-0158-0
- By:
- Publication type:
- Article
Patterns of High-Dose and Long-Term Proton Pump Inhibitor Use: A Cross-Sectional Study in Six South Australian Residential Aged Care Services.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 3, p. 105, doi. 10.1007/s40801-019-0157-1
- By:
- Publication type:
- Article
Re-evaluating Safety and Effectiveness of Dabigatran Versus Warfarin in a Nationwide Data Environment: A Prevalent New-User Design Study.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 3, p. 93, doi. 10.1007/s40801-019-0156-2
- By:
- Publication type:
- Article